Cancer
Malignant Gastric Neoplasm
CI-CAN-00001130Explore in graph →
Top-level652 active trials4 approved drugs55 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00001130Explore in graph →
Clinical trials
2,842 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (232)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00005060 | Combination Chemotherapy and Surgery in Treating Patients With Locally Advanced Stomach Cancer | completed | Phase 3 | 240 | Swiss Cancer InstituteOTHER | 2 | May 15, 2012 | clinicaltrials |
| NCT01583361 | SOX Regimen as Neoadjuvant Chemotherapy for AJCC Stage II-III Gastric Cancer(RESONANCE) | unknown | Phase 3 | 772 | Lin ChenOTHER | 1 | Apr 24, 2012 | clinicaltrials |
| NCT00845611 |
| Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Gastric Cancer |
| completed |
| Phase 1 |
| 9 |
| Kinki UniversityOTHER |
| 1 |
| Apr 6, 2012 |
| clinicaltrials |
| NCT01552980 | Efficacy and Safety Study of a Modified SOX Regimen in First-Line Treatment of Unresectable Gastric Adenocarcinoma(mSOX) | unknown | Phase 2 | 30 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 1 | Mar 28, 2012 | clinicaltrials |
| NCT00660205 | Venous Thromboembolism and Haemostatic Disturbances in Patients With Upper Gastrointestinal Cancer(GIVTE) | completed | — | 285 | University of AarhusOTHER | 1 | Mar 26, 2012 | clinicaltrials |
| NCT00687843 | Study of TS-1 or TS-1 + PSK for Gastric Cancer Patients(TMOG-GC01) | unknown | Phase 3 | 480 | Tokyo Metropolitan Oncology GroupOTHER | 1 | Mar 22, 2012 | clinicaltrials |
| NCT01558947 | Peri-operative Chemotherapy With ECX or XP in the Treatment of Advanced Gastric Cancer | unknown | Phase 2 | 2 | Zhejiang Cancer HospitalOTHER | 1 | Mar 20, 2012 | clinicaltrials |
| NCT01095120 | Tesetaxel as Second-line Therapy for Patients With Advanced Gastric Cancer | unknown | Phase 2 | 27 | Genta IncorporatedINDUSTRY | 2 | Mar 15, 2012 | clinicaltrials |
| NCT01348009 | Tesetaxel Plus Capecitabine and Cisplatin in Advanced Gastric Cancer | unknown | Phase 1 / Phase 2 | 63 | Genta IncorporatedINDUSTRY | 1 | Mar 13, 2012 | clinicaltrials |
| NCT00021047 | Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor | completed | Phase 1 / Phase 2 | — | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 8, 2012 | clinicaltrials |
| NCT00002722 | High-Dose Chemotherapy in Treating Patients With Advanced Stomach Cancer | completed | Phase 2 | 135 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 0 | Mar 5, 2012 | clinicaltrials |
| NCT00429078 | Trial of 2nd Generation Anti-CEA Designer T Cells in Gastric Cancer | withdrawn | Phase 1 | 0 | Roger Williams Medical CenterOTHER | 0 | Mar 2, 2012 | clinicaltrials |
| NCT00821912 | TaxXel: Taxotere and Xeloda in Esophageal Cancer(TaxXel) | unknown | Phase 1 / Phase 2 | 93 | Karolinska University HospitalOTHER | 2 | Feb 28, 2012 | clinicaltrials |
| NCT01147991 | Vaccine Therapy in Treating Patients With Epstein-Barr Virus-Related Cancer | completed | Phase 1 | 16 | Cancer Research UKOTHER | 1 | Feb 28, 2012 | clinicaltrials |
| NCT01212887 | Treated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With Cancer | terminated | Phase 1 | 14 | Cancer Research UKOTHER | 1 | Feb 28, 2012 | clinicaltrials |
| NCT00074009 | Bortezomib in Treating Patients With Unresectable or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 14, 2012 | clinicaltrials |
| NCT00952497 | A Study of Telatinib in Combination With Chemotherapy in Subjects With Advanced Gastric Cancer | completed | Phase 2 | 48 | ACT Biotech, IncINDUSTRY | 2 | Feb 8, 2012 | clinicaltrials |
| NCT01527409 | The Efficacy of Health Partnership Program for Cancer Patients | unknown | N/A | 248 | National Cancer Center, KoreaOTHER_GOV | 1 | Feb 7, 2012 | clinicaltrials |
| NCT01528059 | Roux-en-Y Versus Billroth II Reconstruction After Subtotal Gastrectomy in Gastric Cancer Comorbid With Type II Diabetes | unknown | Phase 2 / Phase 3 | 110 | feng ZhengOTHER | 1 | Feb 7, 2012 | clinicaltrials |
| NCT01319084 | Development of a Versatile Intra-operative On-screen Audiovisual Mentoring System Using TileproTM Program for Robotic Gastrectomy | unknown | — | 60 | Yonsei UniversityOTHER | 1 | Feb 2, 2012 | clinicaltrials |
| NCT01518023 | Long Term Diabetes Improvement After Cancer Gastrectomy and Colectomy | completed | — | 240 | University of Sao PauloOTHER | 1 | Jan 25, 2012 | clinicaltrials |
| NCT00821990 | Second-line Therapy Versus Supportive Care for Pretreated Advanced Gastric Cancer | completed | Phase 3 | 200 | Samsung Medical CenterOTHER | 1 | Jan 20, 2012 | clinicaltrials |
| NCT00661167 | Phase II Study of ABI-007 for Gastric Cancer | completed | Phase 2 | 56 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jan 18, 2012 | clinicaltrials |
| NCT00215995 | Cisplatin and Irinotecan Chemotherapy, Followed by ZD 1839 (Iressa) in Patients With Esophageal or Gastric Carcinomas | completed | Phase 2 | 21 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 2 | Jan 13, 2012 | clinicaltrials |
| NCT00313872 | Phase III Trial of DP Followed by FOLFIRI or the Reverse Sequence in Unresectable Gastric Cancer | completed | Phase 3 | 200 | Samsung Medical CenterOTHER | 1 | Jan 12, 2012 | clinicaltrials |
| NCT01426646 | S-1 Versus S-1 Plus Cisplatin as an Adjuvant Chemotherapy to Treat Gastric Cancer | unknown | Phase 2 | 218 | Kyungpook National University HospitalOTHER | 1 | Jan 5, 2012 | clinicaltrials |
| NCT01366586 | Confocal Laser Endomicroscopy for in Vivo Molecular Imaging of Gastric Cancer by Targeting MG7-Ag | completed | — | 5 | Shandong UniversityOTHER | 1 | Dec 30, 2011 | clinicaltrials |
| NCT01491217 | A Study of Oraxol® in Gastric Cancer Patients | unknown | Phase 1 / Phase 2 | 53 | Hanmi Pharmaceutical Company LimitedINDUSTRY | 1 | Dec 13, 2011 | clinicaltrials |
| NCT01486472 | S-1-induced Lacrimal Drainage Obstruction | unknown | — | 200 | Seoul National University Bundang HospitalOTHER | 1 | Dec 7, 2011 | clinicaltrials |
| NCT01345773 | Incidence of Venous Thromboembolism Following Surgery in Patients With Gastric Cancer | completed | — | 375 | Seoul National University Bundang HospitalOTHER | 1 | Nov 17, 2011 | clinicaltrials |
| NCT01468389 | Taxanes or Platinum in Combination With Capecitabine Followed by Capecitabine Alone as First Line Treatment for Patients With Advanced Adenocarcinoma of Stomach or Esophagogastric Junction | unknown | Phase 3 | 300 | The Affiliated Hospital of the Chinese Academy of Military Medical SciencesOTHER | 1 | Nov 10, 2011 | clinicaltrials |
| NCT00323830 | Phase III Randomized Trial of Adjuvant XP Chemotherapy and XP/RT for Resected Gastric Adenocarcinoma | completed | Phase 3 | 458 | Samsung Medical CenterOTHER | 1 | Nov 9, 2011 | clinicaltrials |
| NCT01464918 | Safety and Efficacy of Using MASTER to Perform Endoscopic Submucosal Dissection in Human | unknown | N/A | 7 | National University Hospital, SingaporeOTHER | 3 | Nov 4, 2011 | clinicaltrials |
| NCT00985556 | Oxaliplatin and S-1 or Oxaliplatin and Capecitabine in Treating Patients With Recurrent, Metastatic, or Unresectable Gastric Cancer | unknown | Phase 2 | 130 | Yonsei UniversityOTHER | 1 | Oct 20, 2011 | clinicaltrials |
| NCT01016639 | Study of Capecitabine and Oxaliplatin in Combination With Radiotherapy in Patients With Unresectable Gastro-Intestinal Cancer(CORGI) | completed | Phase 1 / Phase 2 | 106 | Lund University HospitalOTHER | 1 | Oct 17, 2011 | clinicaltrials |
| NCT00374036 | Metastatic Gastric Cancer FFCD 03-07 | completed | Phase 3 | 416 | University Hospital, ToulouseOTHER | 1 | Oct 12, 2011 | clinicaltrials |
| NCT01048463 | Effect of Enteral Nutrition Rich in Eicosapentaenoic Acid (EPA) on Patients Receiving Chemotherapy for GI Tumor | unknown | Phase 3 | 90 | Sun Yat-sen UniversityOTHER | 1 | Oct 6, 2011 | clinicaltrials |
| NCT01444755 | The Effect of Neoadjuvant Chemotherapy on Locally Advanced Gastric Cancer | unknown | — | 80 | Haydarpasa Numune Training and Research HospitalOTHER | 1 | Oct 3, 2011 | clinicaltrials |
| NCT00865982 | Study to Evaluate Safety and Efficacy of Perioperative Chemotherapy With Docetaxel, Cisplatin and Capecitabine (DCX) in Patients With Gastro-esophageal Cancer(DCXAIOCHARITE) | unknown | Phase 2 | 50 | Charite University, Berlin, GermanyOTHER | 1 | Aug 5, 2011 | clinicaltrials |
| NCT00004233 | S9915 Triacetyluridine, Fluorouracil, and Leucovorin in Treating Patients With Unresectable, Locally Advanced, or Metastatic Cancer of the Esophagus or Stomach | completed | Phase 2 | 65 | SWOG Cancer Research NetworkNETWORK | 1 | Jul 25, 2011 | clinicaltrials |
| NCT01198392 | Trial of S-1 Plus Cisplatin in Gastric Cancer | unknown | Phase 3 | 270 | Sun Yat-sen UniversityOTHER | 1 | Jul 25, 2011 | clinicaltrials |
| NCT00970138 | Apatinib Versus Placebo as a Third Line Treatment in Patients With Advanced or Metastatic Gastric Cancer | completed | Phase 2 / Phase 3 | 141 | Fudan UniversityOTHER | 1 | Jul 12, 2011 | clinicaltrials |
| NCT00150670 | Randomized Phase III Study of TS-1 Alone Versus TS-1 Plus CDDP in Advanced Gastric Cancer | completed | Phase 3 | 300 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jul 7, 2011 | clinicaltrials |
| NCT00152217 | Adjuvant Chemotherapy Trial of TS-1 for Gastric Cancer (ACTS-GC) | completed | Phase 3 | 1,000 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jul 7, 2011 | clinicaltrials |
| NCT00152243 | A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-GC) | completed | Phase 3 | 500 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jul 7, 2011 | clinicaltrials |
| NCT00202969 | Study of S-1, S-1/CDDP, and 5-FU/CDDP for Advanced Gastric Cancer | completed | Phase 3 | 180 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jul 7, 2011 | clinicaltrials |
| NCT00287755 | Clinical Trial of Chemosensitivity Test | completed | Phase 2 | 300 | Japan Clinical Cancer Research OrganizationOTHER | 1 | Jun 29, 2011 | clinicaltrials |
| NCT00287768 | Phase III Study of Docetaxel + S-1 vs. S-1 for Advanced Gastric Cancer | completed | Phase 3 | 628 | Japan Clinical Cancer Research OrganizationOTHER | 1 | Jun 28, 2011 | clinicaltrials |
| NCT00595972 | Epirubicin Cisplatin and Fluorouracil (FU) Combined With Endostar in Patients With Advanced or Metastatic Gastric Cancer | completed | Phase 2 | 25 | Fudan UniversityOTHER | 1 | Jun 28, 2011 | clinicaltrials |
Data updated 22 days agoSource updated May 15, 2012source: clinicaltrials